The effects on depression of Internet-administered behavioural activation and physical exercise with treatment rationale and relapse prevention: study protocol for a randomised controlled trial

Per Carlbring, Philip Lindner, Christopher Martell, Peter Hassmén, Lars Forsberg, Lars Ström, Gerhard Andersson, Per Carlbring, Philip Lindner, Christopher Martell, Peter Hassmén, Lars Forsberg, Lars Ström, Gerhard Andersson

Abstract

Background: Despite their potential as low-threshold, low-cost and high-flexibility treatments of depression, behavioural activation and physical exercise have not yet been directly compared. This study will examine the effects of these interventions, administered via the Internet. The added effect of providing a treatment rationale will also be studied, as well as a relapse prevention program featuring cognitive behavioural therapy components.

Methods/design: This randomised controlled trial will include 500 participants meeting the diagnostic criteria for major depression, recruited in multiple cycles and randomised to either a waiting list control group with delayed treatment, or one of the four treatment groups: (1) physical exercise without a clear treatment rationale; (2) physical exercise with treatment rationale; (3) behavioural activation with treatment rationale; or (4) behavioural activation without a clear treatment rationale. Post treatment, half of the participants will be offered a relapse prevention program. Primary outcome measure will be the Patient Health Questionnaire 9-item. Secondary measures include diagnostic criteria for depression, as well as self-reported anxiety, physical activity and quality of life. Measurements - done via telephone and the Internet - will be collected pre-treatment, weekly during treatment period, immediately post treatment and then monthly during a 24-month follow-up period.

Discussion: The results of this study will constitute an important contribution to the body of knowledge of the respective interventions. Limitations are discussed.

Trial registration: ClinicalTrials.gov: NCT01619930.

Figures

Figure 1
Figure 1
Flow diagram of the trial. PE, physical exercise; BA, behavioural activation; RP, relapse prevention program.

References

    1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, De Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman M, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martínez-Alonso M, Matschinger H. et al.Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;109:21–27.
    1. Murray CJL, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science. 1996;274:740–743. doi: 10.1126/science.274.5288.740.
    1. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87–98.
    1. Spielmans GI, Berman MI, Usitalo AN. Psychotherapy versus second-generation antidepressants in the treatment of depression: a meta-analysis. J Nerv Ment Dis. 2011;199:142–149. doi: 10.1097/NMD.0b013e31820caefb.
    1. Mojtabai R. Unmet need for treatment of major depression in the United States. Psychiatric services (Washington, D.C.) 2009;60:297–305. doi: 10.1176/appi.ps.60.3.297.
    1. Veale D. Behavioural activation for depression. Adv Psychiatr Treat. 2008;14:29–36. doi: 10.1192/apt.bp.107.004051.
    1. Krogh J, Videbech P, Thomsen C, Gluud C, Nordentoft M. DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial. PLoS One. 2012;7:e48316. doi: 10.1371/journal.pone.0048316.
    1. Dimidjian S, Barrera M, Martell C, Muñoz RF, Lewinsohn PM. The origins and current status of behavioral activation treatments for depression. Annu Rev Clin Psychol. 2011;7:1–38. doi: 10.1146/annurev-clinpsy-032210-104535.
    1. Cuijpers P, Van Straten A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev. 2007;27:318–326. doi: 10.1016/j.cpr.2006.11.001.
    1. Addis M, Jacobson N. A closer look at the treatment rationale and homework compliance in cognitive-behavioral therapy for depression. Cogn Ther Res. 2000;24:313–326. doi: 10.1023/A:1005563304265.
    1. Andersson G, Carlbring P, Berger T, Almlov J, Cuijpers P. What makes Internet therapy work? Cogn Behav Ther. 2009;38:55–60. doi: 10.1080/16506070902916400.
    1. Mead GE, Morley W, Campbell P, Greig CA, Marion McMurdo DAL. Exercise for depression. Chichester: John Wiley & Sons, Ltd; 2009.
    1. Rethorst CD, Wipfli BM, Landers DM. The antidepressive effects of exercise: a meta-analysis of randomized trials. Sports Med. 2009;39:491–511. doi: 10.2165/00007256-200939060-00004.
    1. De Moor MHM, Boomsma DI, Stubbe JH, Willemsen G, De Geus EJC. Testing causality in the association between regular exercise and symptoms of anxiety and depression. Arch Gen Psychiatry. 2008;65:897–905. doi: 10.1001/archpsyc.65.8.897.
    1. Keller MB. Long-term treatment of recurrent and chronic depression. J Clin Psychiatry. 2001;Suppl 2:3–5.
    1. Nierenberg A, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry. 2003;Suppl 1:13–17.
    1. Johansson R, Andersson G. Internet-based psychological treatments for depression. Expert Rev Neurother. 2012;12:861–869. doi: 10.1586/ern.12.63.
    1. America Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4. Arlington, VA: APA; 2000.
    1. Svanborg P, Åsberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand. 1994;89:21–28.
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB.
    1. Frisch MB, Cornell J, Villanueva M, Retzlaff PJ. Clinical validation of the Quality of Life Inventory. A measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess. 1992;4:92–101.
    1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–1097. doi: 10.1001/archinte.166.10.1092.
    1. Bondolfi G, Jermann F, Rouget BW, Gex-Fabry M, McQuillan A, Dupont-Willemin A, Aubry J-M, Nguyen C. Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice. J Affect Disord. 2010;121:268–272. doi: 10.1016/j.jad.2009.06.037.
    1. Hedman E, Ljótsson B, Rück C, Furmark T, Carlbring P, Lindefors N, Andersson G. Internet administration of self-report measures commonly used in research on social anxiety disorder: A psychometric evaluation. Comput Hum Behav. 2010;26:736–740. doi: 10.1016/j.chb.2010.01.010.
    1. Holländare F, Andersson G, Engström I. A comparison of psychometric properties between internet and paper versions of two depression instruments (BDI-II and MADRS-S) administered to clinic patients. J Med Internet Res. 2010;12:e49. doi: 10.2196/jmir.1392.
    1. Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;Suppl 20:22–33.
    1. Rohde P, Ph D, Lewinsohn PM, Seeley JR. Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am J Psychiatry. 1997;154:1593–1598.
    1. Addis M, Martell C. Overcoming Depression One Step at a Time. Oakland, CA: New Harbinger Publications; 2004. p. 190.
    1. Holländare F, Johnsson S, Randestad M, Tillfors M, Carlbring P, Andersson G, Engström I. Randomized trial of Internet-based relapse prevention for partially remitted depression. Acta Psychiatr Scand. 2011;124:285–294. doi: 10.1111/j.1600-0447.2011.01698.x.
    1. Thorndike FP, Carlbring P, Smyth FL, Magee JC, Gonder-Frederick L, Ost L-G, Ritterband LM. Web-based measurement: Effect of completing single or multiple items per webpage. Comput Hum Behav. 2009;25:393–401. doi: 10.1016/j.chb.2008.05.006.
    1. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry. 1972;3:257–260. doi: 10.1016/0005-7916(72)90045-6.
    1. Yoon FB, Fitzmaurice GM, Lipsitz SR, Horton NJ, Laird NM, Normand S-LT. Alternative methods for testing treatment effects on the basis of multiple outcomes: simulation and case study. Stat Med. 2011;30:1917–1932. doi: 10.1002/sim.4262.
    1. Löwe B, Gräfe K, Zipfel S, Witte S, Loerch B, Herzog W. Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom. 2004;73:386–390. doi: 10.1159/000080393.
    1. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78:131–140. doi: 10.1016/S0165-0327(02)00237-9.
    1. Löwe B, Unützer J, Callahan CM, Perkins AJ, Lwe B, Uniitzer J, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care. 2004;42:1194–1201. doi: 10.1097/00005650-200412000-00006.
    1. Löwe B, Kroenke K, Herzog W, Gräfe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9) J Affect Disord. 2004;81:61–66. doi: 10.1016/S0165-0327(03)00198-8.
    1. Brooks R, Rabin R, De Charro F. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective: Evidence from the EuroQol BIO MED Research Programme. Rotterdam: Kluwer Academic Publishers; 2003.
    1. Haakkart-van Roijen L, Van Straten A, Donker M, Tiemens B. Manual Trimbos/iMTA questionnaire for Costs associated with Psychiatric illnes (TiC-P) Rotterdam: Institute for Medische Technology Assessment, Erasmus University Rotterdam; 2002.
    1. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61:310–317. doi: 10.1001/archpsyc.61.3.310.
    1. Andersson G, Bergström J, Holländare F, Ekselius L, Carlbring P. Delivering cognitive behavioural therapy for mild to moderate depression via the Internet: predicting outcome at 6-month follow-up. Verhaltenstherapie. 2004;14:185–189. doi: 10.1159/000080914.
    1. Linden M. How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother. 2012 Jan 18. Epub ahead of print.
    1. Proudfoot J, Klein B, Barak A, Carlbring P, Cuijpers P, Lange A, Ritterband L, Andersson G. Establishing guidelines for executing and reporting Internet intervention research. Cogn Behav Ther. 2011;40:82–97. doi: 10.1080/16506073.2011.573807.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren